Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Feb 27, 2015

Genalice Map on AWS

Genalice said this week that Genalice Map, its next-generation sequencing data processing software, is now available via Amazon Web Services.

The company is seeking researchers who would be willing to test-drive the new implementation. Interested parties can sign up for accounts and sign validation agreements on the company's website. Genalice is offering a full month of unlimited testing to the first 25 centers that sign up as in incentive. The company also offers an on-premise implementation of the Map software in its Genalice Vault appliance.

Station X's GenePool Update

Station X said this week that customers of its GenePool platform now have access to datasets from the Cancer Genome Atlas. Specifically, customers will have access to curated genomic profiles from more than 10,000 patients and 27 cancer types along with patient and sample metadata.

10X Genomics' GemCode

10X Genomics this week launched the GemCode sequencing platform at the Advances in Genome Biology and Technology in Marco Island, Fla. GemCode is a molecular barcoding and analysis platform that consists of instrumentation, reagents, and software, and delivers long-range information including haplotype phasing, structural variation, and de novo assembly. The platform partitions arbitrarily long DNA molecules, including those greater than 100 kb, and prepares sequencing libraries in parallel so that all fragments produced within a partition share a common barcode. A simple workflow combines large partition numbers with a massively diverse barcode library to generate more than 100,000 barcode-containing partitions, while only requiring about 1ng of DNA input, the company said.

10X Genomics is accepting purchase orders for the GemCode instrument at $75,000 and will begin shipping in the second quarter of 2015.

Cellular Research's Precise Assays

Cellular Research has launched its Precise Assays for targeted RNA-seq experiments using single cells. Based on Cellular Research's patented molecular indexing technology, the Precise assays examine large numbers of standard or low-input mRNA samples from precious samples, or whenever absolute quantitation is required. The assays combine molecular and sample indexing in 96- and 384-sample formats, enabling customers to sequence up to 4,608 samples in one sequencing run without investment in new equipment or extensive training, Cellular Research said.

Early-access customers and collaborators presented data generated with the assays at the Advances in Genome Biology and Technology conference this week in Marco Island, Fla.

For more recently launched products and services, please see the New Products page on our website.